These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17642863)

  • 41. Common pigmentation disorders.
    Plensdorf S; Martinez J
    Am Fam Physician; 2009 Jan; 79(2):109-16. PubMed ID: 19178061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of fractional photothermolysis: treatment indications and efficacy.
    Tierney EP; Kouba DJ; Hanke CW
    Dermatol Surg; 2009 Oct; 35(10):1445-61. PubMed ID: 19686366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of a novel fractional resurfacing device for treatment of acne scarring.
    Walgrave SE; Ortiz AE; MacFalls HT; Elkeeb L; Truitt AK; Tournas JA; Zelickson BD; Zachary CB
    Lasers Surg Med; 2009 Feb; 41(2):122-7. PubMed ID: 19226575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procedural treatments for acne vulgaris.
    Taub AF
    Dermatol Surg; 2007 Sep; 33(9):1005-26. PubMed ID: 17760592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beneficial effects of spraying low mineral content thermal spring water after fractional photothermolysis in patients with dermal melasma.
    Barolet D; Lussier I; Mery S; Merial-Kieny C
    J Cosmet Dermatol; 2009 Jun; 8(2):114-8. PubMed ID: 19527335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris.
    Fadel M; Salah M; Samy N; Mona S
    J Drugs Dermatol; 2009 Nov; 8(11):983-90. PubMed ID: 19894365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing patient care with "natural" products: treatment of hyperpigmentation.
    Woolery-Lloyd H; Friedman A
    J Drugs Dermatol; 2009 Jun; 8(6 Suppl):s10-3. PubMed ID: 19562884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second-generation 1,550-nm fractional photothermolysis for the treatment of acne scars.
    Chrastil B; Glaich AS; Goldberg LH; Friedman PM
    Dermatol Surg; 2008 Oct; 34(10):1327-32. PubMed ID: 19040687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management of postacne scarring.
    Goodman GJ; Baron JA
    Dermatol Surg; 2007 Oct; 33(10):1175-88. PubMed ID: 17903150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rejuvenation of the aging face using fractional photothermolysis and intense pulsed light: a new technique.
    Mezzana P; Valeriani M
    Acta Chir Plast; 2007; 49(2):47-50. PubMed ID: 17684841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The practicalities of photodynamic therapy in acne vulgaris.
    Taylor MN; Gonzalez ML
    Br J Dermatol; 2009 Jun; 160(6):1140-8. PubMed ID: 19239465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of photodynamic therapy (PDT) for the treatment of acne vulgaris.
    Riddle CC; Terrell SN; Menser MB; Aires DJ; Schweiger ES
    J Drugs Dermatol; 2009 Nov; 8(11):1010-9. PubMed ID: 19894368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Final report on the safety assessment of pentasodium pentetate and pentetic acid as used in cosmetics.
    Benes DM; Burnett CL
    Int J Toxicol; 2008; 27 Suppl 2():71-92. PubMed ID: 18830865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An ophthalmologist's guide to chemical peels.
    Cantisano-Zilkha M
    Ophthalmol Clin North Am; 2005 Jun; 18(2):227-35, v. PubMed ID: 15935284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of beta-carotene topical application in melasma: an open clinical trial.
    Kar HK
    Indian J Dermatol Venereol Leprol; 2002; 68(6):320-2. PubMed ID: 17656988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.